Level of Digitalization in Germany: Results of the Diabetes Digitalization and Technology (D.U.T) Report 2020

Author:

Roos Timm1,Hochstadt Sabine2,Keuthage Winfried3,Kröger Jens4,Lueg Andreas5,Mühlen Hansjörg6,Schütte Lisa7,Scheper Nikolaus8,Ehrmann Dominic1,Hermanns Norbert1,Heinemann Lutz9ORCID,Kulzer Bernhard1ORCID

Affiliation:

1. Research Institute of the Diabetes Academy/Forschungsinstitut der Diabetes-Akademie Bad Mergentheim GmbH (FIDAM), Bad Mergentheim, Germany

2. Freelancer, Berlin, Germany

3. Specialist Practice for Diabetes and Nutritional Medicine/Schwerpunktpraxis für Diabetes und Ernährungsmedizin, Münster, Germany

4. Center for Diabetology/Zentrum für Diabetologie Bergedorf, Hamburg, Germany

5. Diabetes Center/Diabeteszentrum, L1, Hameln, Germany

6. Diabetologicum Duisburg, Duisburg, Germany

7. Lisabetes, Kassel, Germany

8. Practice Dr Med. Scheper & Schneider & Veit, Marl, Germany

9. Science Consulting in Diabetes GmbH, Neuss, Germany

Abstract

Background: New diagnostic and therapeutic technologies are increasingly changing the treatment of people with diabetes (PWD), along with increased usage of digital tools. To date, however, there is little data to which level and how diabetologists and PWD implement digitalization. Also, not much is known about the view of diabetologists on the current status and future developments in this respect. Method: In an online survey, diabetologists working in clinics and practices across Germany provided responses regarding their view on digitalization and the adoption of new technologies in diabetology to 56 questions. These comments reflect the opinion of several experts about the current importance and use of specific digital/technological topics. Results: Overall, 326 diabetologists took part in the survey. They reported a positive attitude (75.8%) toward new technologies and digitalization, and they see more advantages rather than disadvantages. Younger age of the diabetologists was significantly associated with a more positive attitude ( r = −0.176; P < .01), and there was no gender effect ( P = .738). On average, in each practice, 5.5% of PWD are using an insulin pump for therapy, 4.8% a real-time continuous glucose monitoring system, 16.9% an intermittent scanning continuous glucose monitoring system, and 0.3% an automated insulin delivery (AID) system. With respect to digitalization, the three most important current topics are software for glucose data analysis (average rank on a scale from one to six, with one being the most important: 2.4), compatibility with other systems (2.9), and AID systems (3.8)). Conclusions: This survey, which is going to be repeated annually, showed that the diabetologists who participated predominantly have a positive attitude toward new technologies and digital applications and were aware of the associated advantages. However, perceived disadvantages need to be addressed to enable wider adoption of new technologies and digital solutions.

Funder

Berlin-Chemie AG

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3